Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

The Journal of Clinical Medicine is a premier peer-reviewed open-access journal published by MDPI, based in Switzerland. Since its inception in 2012, the journal has carved a niche for itself in the field of medicine, evidenced by its impressive ranking in the 2023 Scopus Ranks, where it stands at #80 out of 636 in General Medicine, placing it in the top 87th percentile. It endeavors to disseminate cutting-edge research that spans various disciplines within medicine, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access available since its launch, the journal ensures that significant medical findings are accessible to a global audience, fostering knowledge exchange and collaboration that is essential in today's rapidly evolving healthcare landscape. The journal's dedication to quality and innovation is further highlighted by its Q1 classification in the 2023 category quartiles for Medicine (miscellaneous), underlining its commitment to advancing clinical knowledge and practice.

MATURITAS is a leading international journal dedicated to promoting high-quality research in the fields of Obstetrics and Gynecology, and Biochemistry, Genetics, and Molecular Biology. Published by Elsevier Ireland Ltd, this prestigious journal boasts an impressive impact factor, consistently ranking in the Q1 quartile in both categories, underscoring its critical role in advancing scientific knowledge and clinical practices. Established in 1978 and spanning through to 2024, MATURITAS facilitates the dissemination of innovative findings and provides crucial insights into women's health and reproductive issues. Researchers, professionals, and students can engage with a wealth of resources, as the journal embraces a wide range of accessible options to foster scholarly communication. With ranks of #10 out of 209 in Medicine and #38 out of 221 in General Biochemistry, Genetics and Molecular Biology according to Scopus, MATURITAS remains at the forefront of research, making it an invaluable resource for those eager to contribute to and expand their understanding in these vital fields.

The Journal of Orthopaedic Translation is a leading peer-reviewed publication dedicated to advancing the field of orthopedics through innovative research and clinical implications. Published by Elsevier and available as an Open Access journal since 2013, it ensures that cutting-edge insights and findings are accessible to a global audience, promoting collaboration and knowledge sharing among researchers, professionals, and students. With an impressive impact factor, the journal has achieved a remarkable Q1 ranking in the categories of Orthopedics and Sports Medicine, placing it in the top 1% of journals in this highly specialized field. As of 2023, it ranks #5 out of 321 in conjunction with a notable 98th percentile achievement in Scopus Ranks, underscoring its reputation for excellence and relevance. Through a focus on both basic and applied research, the Journal of Orthopaedic Translation aims to bridge the gap between laboratory and clinical practice, contributing significantly to the evolving landscape of orthopedic health. Join us in exploring the transformative studies shaping the future of patient outcomes and surgical interventions.

Bone Research is a premier open-access journal published by SpringerNature, dedicated to advancing the understanding of bone biology and its related disciplines. Established in 2013 and based in the United Kingdom, this journal has quickly ascended to the forefront of scientific inquiry, evidenced by its esteemed Q1 rankings in 2023 across multiple categories including Endocrinology, Diabetes and Metabolism, Histology, and Physiology. With a commendable impact reflected in its Scopus ranks—positioned #2 in Histology, #9 in Endocrinology, and #8 in Physiology—Bone Research serves as a vital platform for researchers, healthcare professionals, and students alike to share and access cutting-edge findings. Since adopting an open-access model in 2014, the journal has empowered an expansive audience by facilitating immediate availability of high-quality research. This aligns with its commitment to foster innovation and collaboration within the fields it encompasses. As it converges its efforts from 2013 to 2024, Bone Research remains a critical resource for those looking to deepen their investigation into bone health and diseases, ensuring its place as a leader in promoting scientific excellence.

CONNECTIVE TISSUE RESEARCH is a distinguished academic journal published by Taylor & Francis Inc, dedicated to the study of connective tissue within a broad spectrum of biomedical fields. Since its inception in 1972, this journal has emerged as a crucial platform for disseminating high-quality research findings, exploring fundamental and applied aspects of connective tissue biology. With its convergence stretching to 2024, CONNECTIVE TISSUE RESEARCH showcases innovative research in areas such as biochemistry, orthopedics, rheumatology, and cell biology, making significant contributions to our understanding of tissue structure and function. The journal holds a commendable impact factor and ranks notably in various categories, including a Q2 status in Biochemistry and Orthopedics, reflecting its pivotal role in advancing knowledge in these fields. Researchers and professionals can benefit from its offerings, which include original articles, reviews, and cutting-edge studies, all aimed at enhancing scientific inquiry and clinical applications. The journal remains committed to promoting accessibility through traditional subscription options, ensuring its wide reach in the academic community.

Turk Osteoporoz Dergisi - Turkish Journal of Osteoporosis, published by GALENOS PUBL HOUSE, is a vital resource for researchers and practitioners in the field of endocrinology, diabetes, and metabolism, with a specific focus on osteoporosis. Since its inception as an open-access journal in 2002, it serves to disseminate significant findings and advancements in osteoporosis research, enabling wider access to knowledge in a critical area of health that affects millions worldwide. Despite earning a Q4 categorization in 2023 within its relevant quartile ranks and being positioned at the 7th percentile among its peers in Scopus’ Endocrinology, Diabetes, and Metabolism rankings, the journal actively contributes to the dialogue on osteoporosis, covering essential topics from pathophysiology to treatment strategies. Researchers and professionals can access its contents freely, promoting collaboration and innovation in this dynamic field of study. With an ISSN of 2147-2653, this journal continues to pave the way for improved understanding and management of osteoporosis, making it a cornerstone publication for both seasoned experts and emerging scholars in Turkey and beyond.

Osteoporosis and Sarcopenia is a leading journal dedicated to the multidisciplinary exploration of diseases related to bone health and muscle degeneration, published by Elsevier. With an ISSN of 2405-5255 and an E-ISSN of 2405-5263, this open-access journal has been a vital resource since its inception in 2015, enabling unrestricted access to groundbreaking research. Its objective is to elucidate the interplay between osteoporosis and sarcopenia, offering valuable insights into diagnostics, treatment strategies, and preventive measures in the field. The journal serves as a crucial platform for researchers, healthcare professionals, and students, fostering collaboration and innovation in understanding these prevalent conditions. Given the global rise in aging populations, the significance of this journal cannot be overstated, making it an essential reference for those committed to advancing knowledge in musculoskeletal health.

Osteologie is a distinguished journal published by GEORG THIEME VERLAG KG, focusing on advancing knowledge in the field of osteology and related medical disciplines. With an ISSN of 1019-1291 and E-ISSN 2567-5818, this journal plays a pivotal role in disseminating research that addresses bone health, osteoporotic conditions, and skeletal disorders. Despite its current ranking in Q4 within the broad category of Medicine (miscellaneous), and a Scopus rank placing it at the 15th percentile, Osteologie serves as a platform for emerging research and opinions in a multidisciplinary context. Curating content from 1999 to 2024, it provides valuable insights to researchers, professionals, and students keen on enhancing their understanding of bone health and its implications on overall well-being. With access options available through various academic channels, this journal remains an essential resource for those committed to the exploration and advancement of osteological science.

Aging Clinical and Experimental Research, published by Springer, is a premier journal dedicated to advancing the field of geriatric medicine and understanding the complexities of aging. With a commitment to publishing high-quality original research, review articles, and clinical studies, this journal plays a crucial role in disseminating knowledge to researchers, healthcare professionals, and students interested in the biological, clinical, and social aspects of aging. Boasting a 2023 impact factor that places it in the Q2 quartile for both Aging and Geriatrics and Gerontology categories, it ranks favorably within the Scopus metrics—20th out of 116 in Geriatrics and Gerontology and 15th out of 38 in Aging. The journal provides vital insights for the ongoing discourse in aging research, making it an essential resource for those seeking to enhance their understanding of aging-related phenomena and improve healthcare outcomes across populations. The converged years of publication from 1989 to 2024 demonstrate its longstanding commitment to the field, highlighted by its notable presence in Germany and access to a broad international readership.